|
|
|
Volumn 45, Issue 1161, 2003, Pages 57-58
|
|
Bortezomib (Velcade) for multiple myeloma
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
PYRAZINE DERIVATIVE;
ARTICLE;
ASTHENIA;
CHEMICALLY INDUCED DISORDER;
DOSE RESPONSE;
DRUG ADMINISTRATION;
FEE;
HUMAN;
MULTIPLE MYELOMA;
NAUSEA;
PHARMACOECONOMICS;
PHASE 2 CLINICAL TRIAL;
ANTINEOPLASTIC AGENTS;
ASTHENIA;
BORONIC ACIDS;
CLINICAL TRIALS, PHASE II;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
ECONOMICS, PHARMACEUTICAL;
FEES, PHARMACEUTICAL;
HUMANS;
MULTIPLE MYELOMA;
NAUSEA;
PYRAZINES;
|
|
EID: 0041765751
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (6)
|
|
References (0)
|